Search & Analyze

Blue Jet Healthcare Ltd.

HealthcarePharmaceuticals & Drugs

www.bluejethealthcare.com BSE: 544009NSE: BLUEJET

₹562.10BSE1.76%

16 Sep, 4:01 PM

₹562.10

₹10.68K Cr

77.13

0.00

51.06%

₹574.60

₹543.45

₹725.00

₹325.20

Customise metrics bar

Price Performance

Peer Comparison

Name
SUN PHARMA. SUNPHARMA	1,853.50	36.77	4,44,716.74	0.86	2,901.23	26.53%	15,299.88	10.46%	19.11
DIVI'S LAB. DIVISLAB	9,199.70	83.50	2,44,223.13	0.33	902.00	65.50%	3,080.00	27.80%	21.51
TORRENT PHAR TORNTPHARM	4,823.05	84.11	1,83,453.32	0.79	566.00	3.28%	4,921.00	54.85%	19.27
ZYDUSLIFE ZYDUSLIFE	1,105.00	24.42	1,10,224.17	0.09	990.20	-34.90%	8,017.00	21.96%	21.39
CIPLA LTD. CIPLA	1,359.75	32.59	1,09,848.55	0.96	785.55	-39.18%	7,119.28	2.33%	16.00
LAURUSLABS LAURUSLABS	1,906.00	94.19	1,02,983.51	0.10	362.07	123.94%	2,026.31	29.10%	18.20
DR.REDDY'S DRREDDY	1,145.25	29.67	95,591.76	0.70	435.60	-69.10%	8,099.80	-5.51%	13.75
Blue Jet Healthcare Ltd. BLUEJET	562.10	77.13	10,676.10	0.21					56.68

Quarterly Results

consolidated figures in ₹ Crores · Quarterly

Particulars

Profit & Loss

consolidated figures in ₹ Crores · Annual

Particulars	FY 2019-20 (Mar)	FY 2020-21 (Mar)
No of Months	12.00	12.00
INCOME :
	538.20	498.93
	538.20	498.93
EXPENDITURE :
Increase/Decrease in Stock	23.82	-44.82
Raw Material Consumed	186.60	214.27
Power & Fuel Cost	19.30	19.91
Employee Cost	23.88	28.96
Other Manufacturing Expenses	29.22	33.14
General and Administration Expenses	6.98	8.11
Selling and Distribution Expenses	21.27	24.43
Miscellaneous Expenses	13.42	8.87
	324.47	292.88
Operating Profit (Excl OI)	213.72	206.05
	5.81	8.88
	219.54	214.93
Interest	7.37	5.31
PBDT	212.17	209.63
	18.04	19.66
Profit Before Taxation & Exceptional Items	194.13	189.96
Exceptional Income / Expenses		-5.31
	194.13	184.66
Provision for Tax	49.17	48.87
	144.96	135.79
Minority Interest	-0.11	2.63
Consolidated Net Profit	144.85	138.42
Profit Balance B/F	37.01	181.98
Appropriations	181.85	320.40
	24,141.17	1,396.44
Adjusted EPS	137.95	7.98

Balance Sheet

consolidated figures in ₹ Crores

Particulars	FY 2019-20 (Mar)	FY 2020-21 (Mar)
	0.60	9.91
Share Warrants & Outstandings	9.31
Total Reserves	191.50	329.91
Reserve excluding Revaluation Reserve	191.50	329.91
Revaluation reserve	0.00	0.00
	201.42	339.82
Minority Interest	1.33
Secured Loans	36.93	28.67
Deferred Tax Assets / Liabilities	-1.55	1.38
Other Long Term Liabilities		0.01
Long Term Provisions	2.48	3.29
Total Non-Current Liabilities	37.87	33.35
Trade Payables	52.01	59.53
Other Current Liabilities	58.63	46.11
Short Term Borrowings	17.84	7.13
Short Term Provisions	62.63	107.27
Total Current Liabilities	191.10	220.04
Total Liabilities	431.71	593.21
Gross Block	125.26	176.03
Less: Accumulated Depreciation	18.10	37.11
Net Block	107.16	138.92
Capital Work in Progress	2.04	2.58
Non Current Investments	8.36
Long Term Investment	8.36	0.00
Long Term Loans & Advances	7.40	4.66
Other Non Current Assets	0.09	0.08
Total Non-Current Assets	125.04	146.24
Currents Investments	25.33	36.84
Inventories	69.01	117.72
Sundry Debtors	118.49	144.00
Cash and Bank	15.23	70.45
Other Current Assets	4.43	4.20
Short Term Loans and Advances	74.18	73.77
Total Current Assets	306.67	446.97
Net Current Assets (Including Current Investments)	115.57	226.93
Total Assets	431.71	593.21
Contingent Liabilities	2.02	2.17
Total Debt	77.57	51.55
	32,017.33	3,428.35
Adjusted Book Value	182.96	19.59

Cash Flow

consolidated figures in ₹ Crores

Particulars	FY 2019-20 (Mar)	FY 2020-21 (Mar)
No of Months	12.00	12.00
	194.13	184.66
Adjustment	38.47	17.55
Changes In working Capital	-61.24	-72.73
Cash Flow after changes in Working Capital	171.36	129.48
Cash Flow from Operating Activities	122.73	129.28
Cash Flow from Investing Activities	-45.24	-50.73
Cash Flow from Financing Activitie	-72.50	-27.50
Net Cash Inflow / Outflow	5.00	51.06
Opening Cash & Cash Equivalents	5.08	10.07
Closing Cash & Cash Equivalent	10.07	61.13

Ratios

Valuation

77.13

49.58

21.40

7.31

Profitability

51.06

56.68

26.50

41.30

27.22

Leverage & Liquidity

0.15

2.03

35.79

Returns

0.21

0.97

Shareholding Pattern

Numbers in percentages

Particulars	Jun '24	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	Dec '25	Mar '26	Jun '26
	86.00	86.00	86.00	86.00	86.00	79.81	79.81	79.81	79.81
	4.16	3.92	3.12	3.62	2.91	5.45	5.79	5.39	5.05
	9.83	10.07	10.87	10.38	11.09	14.74	14.41	14.80	15.14
	14.00	14.00	14.00	14.00	14.00	20.19	20.19	20.19	20.19
No. of Shareholders	42,882	41,933	43,003	54,581	70,772	80,117	80,187	79,199	78,917

Corporate Actions

Showing: All

Date	Type	Details	Ex-Date	Record Date
2026-08-18	AGM
2026-07-28	Board Meeting	Quarterly Results
2026-05-25	Ex Dividend	Rs.1.2000 per share(60%)Final Dividend	2026-09-11	2026-09-14

Insider Trading

Date	Person	Category	Transaction Type	Shares	Value (₹)

No insider trading data available.

Sector Overview

HealthcarePharmaceuticals & Drugs

Blue Jet Healthcare Ltd. operates in the Healthcare sector under the Pharmaceuticals & Drugs industry. This sector is one of the key drivers of the Indian economy and is closely tracked by the relevant Nifty sectoral index.

Company Profile

Corporate information and contact details

Key Management

9 members across the board and senior leadership

Sweta Poddar

Company Secretary & Compliance Officer

—

Akshay Bansarilal Arora

Chairman

₹3.60 Cr

Mar '26

Shiven Akshay Arora

Managing Director

₹5.22 Cr

Mar '26

Naresh Suryakant Shah

Whole Time Director

₹5.00 Cr

Mar '26

Popat Kedar

Whole Time Director

₹51.29 L

Mar '26

Girish Paman Vanvari

Non Executive Independent Director

₹20.50 L

Mar '26

Preeti Gautam Mehta

Non Executive Independent Director

₹20.00 L

Mar '26

Divya Sameer Momaya

Non Executive Independent Director

₹13.00 L

Mar '26

Priyanka Yadav

Non Executive Independent Director

₹3.00 L

Mar '26

BLUEJET Latest News

News

10 of 10 articles

EQUITY18 Aug 2026 · 17:31

Blue Jet Healthcare informs about BRSR report

EQUITY7 Aug 2026 · 11:56

Blue Jet Healthcare informs about transcript of earnings call

EQUITY4 Aug 2026 · 14:49

Blue Jet Healthcare informs about press release

EQUITY20 Jul 2026 · 17:18

Blue Jet Healthcare informs about press release

EQUITY14 Jul 2026 · 13:06

Blue Jet Healthcare informs about certificate

EQUITY6 Jul 2026 · 17:03

Blue Jet Healthcare informs about resignation of statutory auditors

EQUITY17 Jun 2026 · 14:01

Blue Jet Healthcare informs about EGM outcome

EQUITY26 May 2026 · 17:25

Blue Jet Healthcare informs about press release

EQUITY26 May 2026 · 17:09

Blue Jet Healthcare informs about press release

EQUITY25 May 2026 · 12:41

Blue Jet Healthcare reports Profit after tax of Rs 643.44 Mln, in the March 2026 quarter

BLUEJET

₹562.10

+1.76%